Investing Profile

Joachim Rothe

VCInvestor
Partner at EQT Life Sciences
Photo of Joachim Rothe, Partner at EQT Life Sciences
cb
$11.0M - $65.0M
$25.0M
16
€260M
CompanyStageDateRound SizeTotal Raised
Binx Health
Series FApr 2024$65M
Series EMay 2021$100M
Series DJan 2017$35M
Series BApr 2014$28M
Series BJul 2011$27M
$280M
Co-investors: Matthew Rizzo (OrbiMed), Florent Gros (Earlybird Venture Capital)
DNA Script
Series COct 2021$170M
Series BJul 2020$50M
Series BMay 2019$39M
$470M
Co-investors: Nick Naclerio (Illumina Ventures), Joško Bobanović (Soffinova Partners), Philippe Peltier (Kurma Partners), George C. Petrocheilos (Catalio Capital)
Innovative Molecules
Series AJun 2021$24M
$24M
Nouscom
Series BNov 2017$49M
$140M
Co-investors: Scott Rocklage (5am Ventures), Hakan Goker (M Ventures (Merck)), Sofia Ioannidou (Andera Partners), Guido Magni (Versant Ventures), Genghis Lloyd-Harris (Abingworth)
Luxendo
Series AJan 2017$8M
Series AOct 2015$7M
$15M
Cellerix
Series CJan 2010$38M
Series BNov 2009$40M
Series BSep 2007$37M
$120M
Co-investors: Joël Jean-Mairet (Ysios Capital)
U3 Pharma
Series UnknownMay 2006$34M
$34M